What's breaking now, across thousands of outlets.
(RTTNews) - On Friday, Ionis Pharmaceuticals (IONS) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended approval of TRYNGOLZA (olezarsen) for adults with severe hypertriglyceridemia (sHTG).
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
DUBAI, United Arab Emirates — Dubai Culture and Arts Authority has revealed that Dubai retained its position as the world’s leading destination for new foreign direct investment (FDI) projects in the…
Key PointsCoreWeave has borrowed over $50 billion to build artificial intelligence (AI) data centers.
(RTTNews) - Element Fleet Management Corp. (EFN.TO), a Canadian mobility solutions firm, on Friday announced the expansion of its partnership with Alphabet Inc.'s (GOOG) self-driving subsidiary Waymo…
The Debt Management Office (DMO) rejected approximately 74% of N1.032 trillion total subscriptions, accepting only N269.06 billion - about 26.07% of the bids received at the October 14 auctions of…
Punjab National Bank (PNB) reported a 13% rise in net profit to ₹5,532 crore for the second quarter ended September 2026, according to a regulatory filing.
